Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid MAXIMUS, Inc. (MMS)?

Page 1 of 2

Is MAXIMUS, Inc. (NYSE:MMS) the right pick for your portfolio? The smart money is turning less bullish. The number of long hedge fund bets stayed the same which is a slightly negative development in our experience.


To the average investor, there are many metrics investors can use to monitor Mr. Market. A couple of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top hedge fund managers can outperform the broader indices by a significant amount (see just how much).

Just as important, positive insider trading sentiment is another way to break down the world of equities. There are a number of motivations for an executive to downsize shares of his or her company, but just one, very obvious reason why they would behave bullishly. Several empirical studies have demonstrated the market-beating potential of this strategy if shareholders understand what to do (learn more here).

With all of this in mind, we’re going to take a gander at the latest action regarding MAXIMUS, Inc. (NYSE:MMS).

What does the smart money think about MAXIMUS, Inc. (NYSE:MMS)?

In preparation for this year, a total of 12 of the hedge funds we track held long positions in this stock, a change of 0% from the third quarter.

When looking at the hedgies we track, Jim Simons’s Renaissance Technologies had the largest position in MAXIMUS, Inc. (NYSE:MMS), worth close to $69.5 million, accounting for 0.2% of its total 13F portfolio. The second largest stake is held by Daruma Asset Management, managed by Mariko Gordon, which held a $67.1 million position; the fund has 4% of its 13F portfolio invested in the stock. Other hedge funds that hold long positions include Chuck Royce’s Royce & Associates, Ken Griffin’s Citadel Investment Group and Cliff Asness’s AQR Capital Management.

Insider trading activity in MAXIMUS, Inc. (NYSE:MMS)

Bullish insider trading is at its handiest when the company we’re looking at has seen transactions within the past six months. Over the latest 180-day time frame, MAXIMUS, Inc. (NYSE:MMS) has seen zero unique insiders purchasing, and 11 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to MAXIMUS, Inc. (NYSE:MMS). These stocks are Lender Processing Services, Inc. (NYSE:LPS), RR Donnelley & Sons Co (NASDAQ:RRD), Ritchie Bros. Auctioneers (USA) (NYSE:RBA), HMS Holdings Corp. (NASDAQ:HMSY), and WEX Inc (NYSE:WXS). This group of stocks are in the business services industry and their market caps match MMS’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!